General information
All standard amino acids were obtained from commercial sources (Sigma Aldrich and ChempImpex); solvents used were reagent grade purity. Thin layer chromatography (TLC) was performed on plastic sheet pre-coated with silica gel 60F 254 (Merck, Darmstadt, Germany) using specified solvent systems. Data collection was done with Masslynx software. Analytical RP-HPLC was performed using an Agilent 1100 Series system (Waldbronn, Germany) with a SUPELCO Discovery BIO Wide Pore ® (Bellefonte, PA, USA) RP C-18 column (15 cm x 2.1 mm, 3 µm). Flow rates of 1 mL/min were used and detection was done at 215 nm. The solvent system consisted of 0.1% TFA in water and 0.1% TFA in acetonitrile. The gradient consisted of a 20 min run from 3 to 97% or 30 to 70% acetonitrile at a flow rate of 0.3 mL/min. Preparative HPLC was performed on a Gilson apparatus and controlled with the software package Unipoint.
The reversed phase C18-column (SUPELCO Discovery BIO Wide Pore 25 cm x 21.2 mm, 10 µm) was used under the same conditions as the analytical RP-HPLC, but with a flow rate of 20 mL/min. A purity of more than 95% was determined for all compounds by analytical RP-HPLC using the conditions described above. HRMS data was recorded with a Micromass QTOF-micro system using electrospray (ESP) ionization (positive or negative ion mode). Mass spectra were recorded with a LCMS-MS triple-quadrupole system. Visualization of the products on TLC plates was realized using UV light (254 nm), KMnO 4 spray. Reactions were performed using a Biotage ® Initiator + SP Microwave Synthesizer. All commercial reagents and solvents were used without further purification. 
Solution-phase peptide synthesis of (3a-h) and (4a-h)
Peptide synthesis of (3a-h) and (4a-h) in solution: (Coupling, Boc Deprotection, Saponification, Allylation, Debenzylation and ICMR reactions)
Coupling:
To amino acid (AA).TFA or HCl salt (1 equiv.) in EtOAc was added DIEA (2 equiv.), T3P (2 equiv.) and the corresponding Boc-AA-OH or Butenoïc acid (1 equiv) was dissolved in EtOAc.
The mixture was stirred for 2 h, and then extracted with water, citric acid and brine. The organic layer was dried over MgSO 4 , and after filtration, the residue was evaporated to afford the desired peptide as a white solid in good purity determined by RP-HPLC and LC-MS. No further purification was necessary.
Boc Deprotection:
Boc-protected peptide was dissolved in a mixture of TFA/CH 2 Cl 2 : 50/50. The reaction was stirred for 2 h, and the mixture was evaporated. Purified TFA salts were used in the next reactions after precipitation in Et 2 O and filtration (Characterized by RP-HPLC and LCMS). No further purification was necessary.
Saponification:
Benzyl ester (1 equiv.) was dissolved in THF/H 2 O : 80/20 (0.2 M), and LiOH (1.5 equiv.) was added. The reaction was monitored by RP-HPLC, and after 2 h, it was complete. The mixture was poured into 1:1 EtOAc-H 2 O (5 mL) then was acidified to pH 4 by 1N HCl, and extracted with EtOAc (3 x 10 mL). The organic layers were combined and washed with brine (10 mL).
The organic phase was evaporated to afford the corresponding peptide in good yields as yellow oil (determined by RP-HPLC and LC-MS). No further purification was necessary.
Allylation:
A mixture of free carboxylic acid peptide derivatives (1 equiv.), K 2 CO 3 (2 equiv), Bu 4 NI (0.1 equiv), and alkyl bromide (1.1 equiv.) in DMF (0.05 M) was stirred at r.t. for 18 h. After the addition of a 1 M aqueous solution of KHSO 4 (25 mL), the product was extracted with ethyl acetate (3 x10 mL). The organic phase was washed with a saturated aqueous solution of NaHCO 3 (10 mL), an aqueous saturated solution of NaCl (20 mL), and then dried over Na 2 SO 4 .
Evaporation of the solvent afforded the corresponding ester as yellow oil with excellent purity determined by RP-HPLC and LC-MS. The peptide was purified by RP-HPLC on a Supelco Discovery BIO wide pore preparative C18 column in good overall yield and was >95% pure as determined by analytical RP-HPLC and, the structure of pure compounds was confirmed by high-resolution electrospray ionization (ESP) mass spectrometry.
One-pot tandem Isomerization/Cross-Metathesis/Reduction/Cleavage:
The purified tetrapeptides 3 or 4 (0.1 mmol) (Figure 2) was removed by hydrogenation. 20% Pd/C (0.04 mmol) was added to a solution of amino-ester TFA salt (0.4 mmol) in MeOH (10 mL). The reaction was stirred under H 2 -atmosphere at room temperature for 24 h. After filtration through Celite and concentration under reduced pressure, the desired product was obtained in good purity as a white solid. The peptides were isolated by filtration and purified by RP-HPLC on a Supelco Discovery BIO wide pore preparative C18 column in moderate overall yield and was >95% pure as determined by analytical RP-HPLC and,
The structure of pure compounds was confirmed by high-resolution electrospray ionization (ESP) mass spectrometry. This reaction conducted to the formation of seven isolated peptides of (3a-h) and seven isolated peptides of (4a-h) (Figure 3 ).
Benzyl-ester deprotection:
To obtain the final products (4a-h) after the ICMR ractions, the benzyl ester was removed by hydrogenation. 20% Pd/C (0.1 equiv.) was added to a solution of amino-ester TFA salt (1 equiv.)
in MeOH (0.1 M). The reaction was stirred under H 2 -atmosphere at room temperature for 24 h.
After filtration through Celite and concentration under reduced pressure, the desired product was obtained in good purity as a white solid. The resulted peptides were purified by RP-HPLC in excellent purity as determined by analytical RP-HPLC and, the structure of pure compounds was confirmed by high-resolution electrospray ionization (ESP) mass spectrometry. 
H-Tyr-Tic-Phe-Phe-Opropyl (3a

Reduction of C=C double bonds (Alkene):
20% Pd/C (0.2 mmol) was added to a solution of amino-ester (2 mmol) in MeOH (10 mL). The reaction was stirred under H2-atmosphere at room temperature for 24 h. After filtration through Celite and concentration under reduced pressure, the desired product was obtained in good purity (determined by RP-HPLC and LC-MS) as a brown oil (Figure 6 ). 
Saponification:
Methyl ester (1.78 mmol) was dissolved in THF/H 2 O 80:20 (50 mL), and LiOH (2.67 mmol) was added. The reaction was monitored by RP-HPLC, and after 2.5 h, it was complete. The mixture was poured into 1:1 EtOAc-H 2 O (50 mL) then was acidified to pH 4 with 1N HCl, and extracted with EtOAc (3 x 20 mL). The organic layers were combined and washed with brine (30 mL).
The organic phase was dried over MgSO 4 , and after filtration, the mixture was evaporated to afford the corresponding amino-acid in good yields as yellow or off white oil (determined by RP-HPLC and LC-MS) (Figure 7 ). test. In case of a positive color test, the coupling was repeated until a negative test was obtained.
The next amino-acid was consecutively coupled using the procedure described above. Fmoc deprotections were carried out by treating the resin twice (5 and 30 min) with 20% 4-methyl piperidine in DMF. Final cleavage of the peptide from the resin as well as the Boc side chain protection group removal was accomplished by treatment with TFA/Et 3 SiH/water 60:35:5 for 2 hours. The peptide was isolated by filtration and purified by RP-HPLC on a Supelco Discovery BIO wide pore preparative C18 column in good overall yield and was >95% pure as determined by analytical RP-HPLC and, the structure of pure compounds was confirmed by high-resolution electrospray ionization (ESP) mass spectrometry (Figure 8) . Table 3 Fmoc-Phe-Wang resin was swollen in DMF (3 mL) for 30 min. In a separate 5 mL glass vial, a solution of Fmoc-protected amino acid (Fmoc-Xaa-OH, 3 equiv.), TBTU (3 equiv.) and DIEA (6 equiv.) in DMF (3 mL) was stirred for 10 min and added to the swollen resin. Under microwave irradiation (Biotage SP Wave, 75 °C, power was set at 400 W), the mixture was shaken for 5 min with Fmoc-Phe-OH, 5 min with Fmoc-Tic-OH, and 5 min with Boc-Tyr(tBu)-OH or BocTyr(All)-OH. The next amino-acid was consecutively coupled using the procedure described above. After each coupling step, the resin was washed with DMF and the Fmoc protecting group was removed with 20% 4-methyl-piperidine in DMF for 20 min at room temperature without irradiation. Next, the resin was filtered and respectively washed by vortexing for 1 min with DMF (3 x 3 mL), MeOH (3 x 3 mL) and CH 2 Cl 2 (3 x 3 mL) to afford the tetrapeptides 5 and 6 linked to Wang resin. For structure confirmation, a microcleavage of the peptide from the resin by treatment with TFA/CH 2 Cl 2 /TES/H 2 O 60:35:2.5:2.5 for 2 hours, followed by LCMS analysis, gave the desired peptides 5 and 6 with excellent purity. After completion of the coupling, the resin was transferred into a sealed dry vial containing 3 mL of dry CH 2 Cl 2 then, 1-hexene (0.4 mmol) and Umicore M2 catalyst (0.01 mmol) were added consecutively. The solution was heated at 50 °C for 24 h. Rh(I)-catalysed homogeneous hydrogenation using Umicore M2 (0.01 mmol) in the presence of Et 3 SiH (1 mmol) effected quantitative reduction of the resin-attached alkene at 50°C in CH 2 Cl 2 for 48 hours. The resin was washed three times with DMF, three times with i-PrOH and three times with CH 2 Cl 2 . Final cleavage of the peptide from the resin as well as the Boc side chain protection group removal was accomplished by treatment with TFA/DCM/Et 3 SiH/H 2 O 60:35:2.5/2.5 for 2 hours. The peptides were isolated by filtration and purified by RP-HPLC on a Supelco Discovery BIO wide pore preparative C18 column in good overall yield and was >95% pure as determined by analytical RP-HPLC and, the structure of final pure compounds was confirmed by high-resolution electrospray ionization (ESP) mass spectrometry. Table 5 ).
Peptide Characterization. H-Tyr(ethyl)-Tic-Phe-Phe-OH (6a'
)
Microwave-assisted solid-phase synthesis of tetrapeptides (5a-h) and (6a-h) via the tandem isomerization/cross-metathesis/reduction reactions (Pathway B) (See
Peptide Characterization. Propyl-CO-Tyr-Tic-Phe-Phe-OH (5a
Solid-phase synthesis of tetrapeptides (7a-h) via the tandem isomerization/crossmetathesis/reduction reactions (ICMR) (See
The linear tetrapeptides were synthesized manually by N 
Synthesis of H-
